Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
BMC Cancer|August 28, 2014
MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinomaZhao Sun, Changting Meng, Shihua Wang, et al.
Stem Cell Research & Therapy|July 23, 2022
Mesenchymal stem cells derived from adipose accelerate the progression of colon cancer by inducing a MT-CAFs phenotype via TRPC3/NF-KB axisChunling Xue, Yang Gao, Xuechun Li, et al.
Frontiers in Oncology|August 26, 2022
Mesenchymal stem cells derived from adipose tissue accelerate the progression of colon cancer by inducing a MTCAF phenotype via ICAM1/STAT3/AKT axisChunling Xue, Yang Gao, Zhao Sun, et al.
The Plant Journal : for Cell and Molecular Biology|August 21, 2025
Comprehensive analysis of DNA methylome and transcriptome reveals the epigenetic regulation of nitric oxide treatment in delaying apricot fruit senescenceYuanye Jiang, Jiejie Tao, Jinhua Zuo, et al.
International Immunopharmacology|April 14, 2024
Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinomaHui Tang, Tingting You, Hui Ge, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 23, 2025
Steroid Receptor Coactivator-1 Drives Tumor-Associated Macrophage Reprogramming by Mediating MMP12 Transcription in Pancreatic Cancer Perineural InvasionKe Cheng, Liang Liu, Miaomiao Gong, et al.
The Plant Journal : for Cell and Molecular Biology|November 4, 2024
The dynamic N1-methyladenosine RNA methylation provides insights into the tomato fruit ripeningLili Ma, Jinhua Zuo, Chunmei Bai, et al.
Medcomm|June 25, 2026
Dynamics of Circulating Tumor DNA (ctDNA) Predict Treatment Efficacy and Prognosis in Patients With Advanced Pancreatic Cancer: A Prospective Large-Cohort StudyTingting You, Hui Tang, Mingming Yuan, et al.
Frontiers in Immunology|February 5, 2026
Single-center experience with immune checkpoint inhibitor-related ureteritis and cystitisChenyu Wang, Muwen Nie, Yuan Liu, et al.
British Journal of Cancer|May 13, 2016
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancerXiang Wang, Lin Zhao, Hongfeng Liu, et al.
Pageof 17